← Leaderboards
Michael H Bloch
Yale University
$4,546,615
Attributed
$6,232,690
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,232,690 · 3
By mechanism
T32$3,372,150 · 1
R01$1,958,386 · 1
K23$902,154 · 1
Top collaborators
- Michael J Crowley7 shared
Most similar at Yale University
Same institution · by research overlap
- Matthew W State$28,201,965
- Dustin Scheinost$8,044,506
- R. Todd Constable$27,324,295
- Mitchell J Prinstein$7,284,031
- Robert T Malison$17,226,399
Others in their field
Top investigators on “Childhood”
- Gregory H Reaman · National Childhood Cancer Foundation$268,060,146
- Barbara Driver · Westat, Inc.$206,410,885
- Sharon A Nachman · Johns Hopkins University$191,166,598
- Peter C Adamson · National Childhood Cancer Foundation$190,988,407
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$187,267,729
- James E. Gern · University Of Wisconsin-Madison$149,875,125
Research focus
ChildhoodTraining ProgramsDesignAdolescentNeuropsychiatric DisorderAdultPsychiatryNeuroimagingSymptomsChildBrainBaseAreaClinical ResearchClinical AssessmentsClinicClinical CareCognitive ControlCharacteristicsBasal GangliaAwardAmericanChronic DiseaseBiological Psychiatry
Grant awards (15)
Training Program in Childhood Neuropsychiatric Disorders$523,754
T32 · FY2025 · MH
Training Program in Childhood Neuropsychiatric Disorders$516,421
T32 · FY2024 · MH
Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine$643,249
R01 · FY2023 · MH · contact PI
Training Program in Childhood Neuropsychiatric Disorders$516,677
T32 · FY2023 · MH
Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine$653,324
R01 · FY2022 · MH · contact PI
Training Program in Childhood Neuropsychiatric Disorders$495,099
T32 · FY2022 · MH
Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine$661,813
R01 · FY2021 · MH · contact PI
Training Program in Childhood Neuropsychiatric Disorders$466,424
T32 · FY2021 · MH
Training Program in Childhood Neuropsychiatric Disorders$445,443
T32 · FY2020 · MH
Training Program in Childhood Neuropsychiatric Disorders$408,332
T32 · FY2019 · MH
Longitudinal Structural MRI Study of Adulthood Outcome in Tourette Syndrome$179,974
K23 · FY2014 · MH · contact PI
Longitudinal Structural MRI Study of Adulthood Outcome in Tourette Syndrome$180,360
K23 · FY2013 · MH · contact PI
Longitudinal Structural MRI Study of Adulthood Outcome in Tourette Syndrome$180,759
K23 · FY2012 · MH · contact PI
Longitudinal Structural MRI Study of Adulthood Outcome in Tourette Syndrome$180,365
K23 · FY2011 · MH · contact PI
Longitudinal Structural MRI Study of Adulthood Outcome in Tourette Syndrome$180,696
K23 · FY2010 · MH · contact PI